Fredrik Axling
Doktorand vid Institutionen för kirurgiska vetenskaper; Endokrinkirurgi
- E-post:
- fredrik.axling@uu.se
- Besöksadress:
- Akademiska sjukhuset, ingång 70, 1 tr
751 85 UPPSALA - Postadress:
- Akademiska sjukhuset, ingång 70, 1 tr
751 85 UPPSALA
- ORCID:
- 0000-0003-3748-3176
Mer information visas för dig som medarbetare om du loggar in.
Kort presentation
Denna text finns inte på svenska, därför visas den engelska versionen.
My PhD studies are focused on the endocrine tumorigenesis, with a special interest in genomic and transcriptomic alterations occurring during the endocrine pathophysiology.
Nyckelord
- adrenal gland tumors
- aldosterone-producing adenomas
- apas
- cancer genomics
- functional genomics
- next generation sequencing
- rna-seq
- rna-sequencing
- si-nets
- small intestinal neuroendocrine tumor
- transcriptomics
- wgs
- whole genome sequencing
Forskning
Denna text finns inte på svenska, därför visas den engelska versionen.
The focus of my thesis is to better understand the underlying mechanics regarding the functional genomics of endocrine tumorigenesis, specifically in the adrenal gland and small intestinal neuroendocrine tumors.
Publikationer
Senaste publikationer
- High iNOS and IL-1β immunoreactivity are features of colitis-associated colorectal cancer tumors, but fail to predict 5-year survival (2023)
- Optimizing zebrafish rearing-Effects of fish density and environmental enrichment (2023)
- Haptoglobin in Juvenile Idiopathic Arthritis (2022)
- A dominant negative splice variant of the heparan sulfate biosynthesis enzyme NDST1 reduces heparan sulfate sulfation (2022)
Alla publikationer
Artiklar
- High iNOS and IL-1β immunoreactivity are features of colitis-associated colorectal cancer tumors, but fail to predict 5-year survival (2023)
- Optimizing zebrafish rearing-Effects of fish density and environmental enrichment (2023)
- Haptoglobin in Juvenile Idiopathic Arthritis (2022)
- A dominant negative splice variant of the heparan sulfate biosynthesis enzyme NDST1 reduces heparan sulfate sulfation (2022)
